The market showed a negative development Monday, and Cdax-Gesamtindex (Perf) ended the day at 1693 points, which is a decline of 3.8 percent. The index thereby broke the earlier bottom it set Jan 3 and reached a new year-low. The index has now closed down for the fourth day in a row and this past month the index has lost as much as 15.5 percent. 55 shares showed a gain and 218 showed a loss. 12 shares were unchanged and closed at the same price as the previous day. There was no trading in 17 shares. Total value of the trading volume for shares and primary capital certificates Monday was approximately 15.8 billion. | |
Branicks Group AG | 11.76% |
Heidelberger Beteiligungsh | 7.04% |
Gelsenwasser AG | 6.80% |
Your Family Enter.Ag | 5.82% |
Medigene AG | 5.76% |
Tiscon AG | -30.53% |
Arzneiwerk AG VIDA | -30.23% |
TTLBeteiligungs- und Grund | -23.48% |
Softing AG | -14.04% |
Singulus Technologies AG | -13.16% |
Rheinmetall AG | 2071.70 |
Sap SE | 1526.62 |
Allianz SE | 1203.79 |
Siemens AG | 926.46 |
Deutsche Telekom AG | 793.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.